↓ Skip to main content

Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials

Overview of attention for article published in Thorax, October 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Citations

dimensions_citation
122 Dimensions

Readers on

mendeley
124 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials
Published in
Thorax, October 2012
DOI 10.1136/thoraxjnl-2012-201926
Pubmed ID
Authors

Yaa-Hui Dong, Hsien-Ho Lin, Wen-Yi Shau, Yun-Chun Wu, Chia-Hsuin Chang, Mei-Shu Lai

Abstract

The active-treatment comparative safety information for all inhaled medications in patients with chronic obstructive pulmonary disease (COPD) is limited. We aimed to compare the risk of overall and cardiovascular death for inhaled medications in patients with COPD.

X Demographics

X Demographics

The data shown below were collected from the profiles of 41 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 2 2%
Colombia 1 <1%
France 1 <1%
Italy 1 <1%
Brazil 1 <1%
Chile 1 <1%
Tunisia 1 <1%
United Kingdom 1 <1%
Spain 1 <1%
Other 1 <1%
Unknown 113 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 28 23%
Other 23 19%
Student > Ph. D. Student 14 11%
Student > Master 12 10%
Student > Postgraduate 10 8%
Other 27 22%
Unknown 10 8%
Readers by discipline Count As %
Medicine and Dentistry 77 62%
Pharmacology, Toxicology and Pharmaceutical Science 11 9%
Agricultural and Biological Sciences 7 6%
Biochemistry, Genetics and Molecular Biology 4 3%
Nursing and Health Professions 3 2%
Other 7 6%
Unknown 15 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 47. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2018.
All research outputs
#807,210
of 23,905,714 outputs
Outputs from Thorax
#293
of 5,471 outputs
Outputs of similar age
#4,479
of 174,474 outputs
Outputs of similar age from Thorax
#1
of 76 outputs
Altmetric has tracked 23,905,714 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,471 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.8. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,474 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.